Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.
about
Mechanisms of oestrogen receptor (ER) gene regulation in breast cancerMinireview: Conversing with chromatin: the language of nuclear receptorsNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasWDR5 Expression Is Prognostic of Breast Cancer Outcome.Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Chaperonin CCT-mediated AIB1 folding promotes the growth of ERα-positive breast cancer cells on hard substratesChanges in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E2 TreatmentTransient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes.Nuclear receptor modulation--role of coregulators in selective estrogen receptor modulator (SERM) actions.A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples.Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells.Structure of a biologically active estrogen receptor-coactivator complex on DNA.Early programing of uterine tissue by bisphenol A: Critical evaluation of evidence from animal exposure studies.Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technologyPharmacogene regulatory elements: from discovery to applicationsGerm-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patientsUnique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cellsThe transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signalsEpigenetic regulation of estrogen signaling in breast cancerInteraction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface.Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics.Estrogen represses gene expression through reconfiguring chromatin structures.Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement.Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.Targeting nuclear receptors with marine natural products.Long-range transcriptional regulation of breast cancer genes.Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion model.The Estrogen Receptor α-Cistrome Beyond Breast Cancer.The histone variant H2A.Z is an important regulator of enhancer activity.Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors.GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibilityLow-Cell-Number Epigenome Profiling Aids the Study of Lens Aging and Hematopoiesis.Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.Oestrogen receptor–co-factor–chromatin specificity in the transcriptional regulation of breast cancer.Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages.Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor.Parallel factor ChIP provides essential internal control for quantitative differential ChIP-seq.A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes.
P2860
Q26765380-C5124914-9E3B-4F21-B63A-B1DD73F3A692Q26829103-A2F0CDFD-107E-4332-B385-CA25859E60CAQ28567562-5F4E2E7D-5404-442C-B2CF-7A8101D12209Q30402762-1742877B-9CE5-4570-AE9D-3FDA7B9FCA79Q31034941-52C42C1A-E3B1-4794-8413-0A96D208F194Q33553729-B193809C-029F-4AC0-BA67-0A0C541CF5D5Q33663242-8CA68D86-FA2D-4378-B30E-78CD129E0612Q34131693-EE5D3B37-1B44-419E-A137-3B137D63D55CQ34315391-14C22C4A-12D2-4CAB-831E-FDDCC547C569Q34658939-BE6BC961-057F-4FD0-8011-23E4953CFFDDQ34921964-5394C26C-AFC5-40ED-99A1-095EC702CA0AQ35205425-0BF62124-9095-48C0-9C0F-A75203418D49Q35998342-88A53DE5-6708-4C66-B9B9-37D27B0C159CQ36063718-B5B74C70-F39C-4CF8-AD44-3E1508A1E11FQ36424755-078E34B8-DFE8-49A4-B26E-BAD0C2A559B6Q36562289-83A491AD-C3CE-479E-8123-343B4ECAA531Q36627165-4682175C-3A26-4AB6-B14C-C116C48839A8Q36637419-F8BB6429-476C-4442-AF4D-A571C8D2F5A9Q36640852-81A039C1-2068-4C55-90AF-C096030D64E5Q36891892-69ECC076-A592-436E-B2B5-6F46039634B4Q36895738-8ED90195-DC5A-4A18-AEA3-A4BE14247A98Q37094009-5D52ED65-CF43-4822-9C06-7ED579FE333BQ37197796-418E030E-F96E-49BE-9728-2B3193C25DFAQ37234543-1D9F0E4F-CC4C-4851-BE96-ACA861209CF9Q37528787-10356649-9A10-4194-B1F0-8694AE43B3C5Q37621100-414D83C9-10D0-4D25-8945-E3BFDB3CAFCDQ38053130-D1A04725-2100-4016-A49C-4E022171DE97Q38489025-537F7E3E-B60C-46F0-A782-1D6616A5DF04Q38917972-34E9F68E-2BB6-49C3-BED6-86A0C0F33D5FQ38934752-3A877F4F-25B0-4ABC-89C1-D1114B975CB4Q38975294-32D5EE3F-B792-4456-86CB-B919C93B3882Q39240915-FC0291F4-82EF-4AAF-BC5A-18A86082ADFFQ42149226-DEF26EB8-835F-4DC7-AB98-529CE1469B2CQ42778124-60CDE51F-40F7-4427-8C06-CF349B18B54DQ46101987-7BDC31D1-6655-4A95-8375-6F60182CB8C7Q47144286-9EFCF629-BA18-4F88-9B71-8EF163179370Q48112811-60588556-4C13-4230-A485-C76F9E087082Q50986605-3988D0DE-46B8-4689-8BAE-F81496E2A1B4Q52577825-E2C5FDF1-87E0-4DBA-8061-CF16DB4C5B0AQ55440426-845054EE-84D8-41FC-84A9-3C5B7CAC4896
P2860
Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oestrogen receptor-co-factor-c ...... l regulation of breast cancer.
@ast
Oestrogen receptor-co-factor-c ...... l regulation of breast cancer.
@en
type
label
Oestrogen receptor-co-factor-c ...... l regulation of breast cancer.
@ast
Oestrogen receptor-co-factor-c ...... l regulation of breast cancer.
@en
prefLabel
Oestrogen receptor-co-factor-c ...... l regulation of breast cancer.
@ast
Oestrogen receptor-co-factor-c ...... l regulation of breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Oestrogen receptor-co-factor-c ...... al regulation of breast cancer
@en
P2093
Jason S Carroll
Marleen Kok
Sabine Linn
Sander Canisius
P2860
P304
P356
10.1038/EMBOJ.2011.368
P407
P577
2011-10-14T00:00:00Z